Lyell Immunopharma, Inc. (LYEL) at a glance

Lyell Immunopharma, Inc. (LYEL) is a Healthcare company. It trades at $12.58. It does not pay a dividend. Vestovix scores it 47/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (20/100).

Price

$12.58

Market cap

n/a

P/E ratio

n/a

Dividend yield

None

Beta

n/a

52-week range

$8.46 to $45.00